What Happened?
South San Francisco, CA-based CytomX Appointed Matt Paulson as Development Chief of Staff
Date of management change: October 15, 2020
South San Francisco, CA-based CytomX Appointed Matt Paulson as Development Chief of Staff
CytomX Therapeutics is a clinical-stage biopharmaceutical company with a deep and differentiated oncology pipeline of investigational Probody™ therapeutics. Probody therapeutics are designed to exploit unique conditions of the tumor microenvironment to more effectively localize antibody binding and activity while limiting activity in healthy tissues. The Company`s pipeline includes proprietary cancer immunotherapies against clinically-validated targets, such as PD-L1, and first-in-class Probody drug conjugates against highly attractive targets, such as CD166 and CD71, which are considered to be inaccessible to conventional antibody drug conjugates due to their presence on healthy tissue. In addition to its wholly owned programs, CytomX has strategic collaborations with AbbVie, Amgen, Bristol-Myers Squibb Company, MD Anderson Cancer Center and ImmunoGen, Inc.
Matt Paulson is Development Chief of Staff at CytomX. Previously, Matt held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Tierney Mariana, Arnold Drew, Small Steve, Whalin John, Zanfardino Leslie, Frazier John, Spiesman Wendy, Brooks Ida, Stolt Sharon, Van Houten Allison, Mikkelsen Robert
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.